Nitches Inc. (OTC PINK:NICH) proudly announces a significant milestone in its journey toward nationwide expansion: InTheZone Labs, its premium supplement brand, is now live on ShareASale, one of the ...

Kirtlington, Oxfordshire, UK / 14th November 2024 / 2BScientific Limited proudly announces the opening of its first European hub in Munich, Germany, establishing a strong base to service the growing ...

InsolvencyMarinomed Biotech AG announces unanimous approval of the restructuring plan by creditors 14-Nov-2024 / 14:34 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the ...

WASHINGTON, DC / ACCESSWIRE / November 14, 2024 / Zane Networks, LLC, a leader in healthcare transformation services and solutions, has been awarded a Blanket Purchase Agreement (BPA) by the Office of ...

POTOMAC, MD / ACCESSWIRE / November 14, 2024 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced its financial results and strategic advancements for the second fiscal ...

The integration of AI in life science recruitment is already reshaping hiring processes by offering increased efficiency, ...

Combined with Zomedica's eACTH assay, equine veterinarians get same day answers for their PPID and EMS patients ANN ARBOR, MI / ACCESSWIRE / November 14, 2024 / Zomedica Corp. (NYSE American:ZOM) ...

Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, marked the sixth anniversary since its ...

Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces that the Center for Devices and Radiological Health (CDRH) ...

Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, ...

MinervaX ApS, a privately held Danish biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus (GBS), today announced the appointment of Veronica Gambillara Fonck ...

Vect-Horus, a privately held biotechnology company that designs and develops molecular vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, today announced the ...